Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and labeled with anti-RSV F protein/gold ... Sales of both GSK’s and Pfizer’s vaccines for ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

What are the lasting impacts of RSV, and how can you prevent your infant from getting the infection? Dr. Stephania Cormier is ...

It's common knowledge that winter is flu season - but serious respiratory illnesses tracked by the Centers for Disease Control go beyond ... States tracks levels of RSV, Influenza-A and COVID ...

It's common knowledge that winter is flu season - but serious respiratory illnesses tracked by the Centers for Disease Control go beyond influenza. A CDC dashboard on respiratory virus activity levels ...

Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants and a significant cause of respiratory infections in the elderly and adults with chronic obstructive ...

Live your life healthier and happier with our free weekly Living Well newsletter Older adults in England are being urged by health officials to get vaccinated against respiratory syncytial virus ...

Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 RSV vaccine Abrysvo specifically floundered in the fourth quarter. The product's sales fell 62% year over year to $198 ...